Moore Capital Management LP Makes New $397,000 Investment in Accolade, Inc. (NASDAQ:ACCD)

Moore Capital Management LP bought a new position in Accolade, Inc. (NASDAQ:ACCD) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 116,204 shares of the company’s stock, valued at approximately $397,000. Moore Capital Management LP owned 0.14% of Accolade at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Laird Norton Wetherby Trust Company LLC bought a new stake in Accolade in the 4th quarter worth approximately $38,000. Lightspeed Management Company L.L.C. bought a new stake in shares of Accolade during the 4th quarter valued at $228,000. Graham Capital Management L.P. bought a new stake in shares of Accolade during the 4th quarter valued at $265,000. D. E. Shaw & Co. Inc. grew its position in shares of Accolade by 77.9% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,280,783 shares of the company’s stock valued at $7,800,000 after acquiring an additional 998,423 shares during the period. Finally, Cubist Systematic Strategies LLC grew its position in shares of Accolade by 40.8% during the 4th quarter. Cubist Systematic Strategies LLC now owns 668,738 shares of the company’s stock valued at $2,287,000 after acquiring an additional 193,754 shares during the period. Institutional investors own 84.99% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Piper Sandler downgraded shares of Accolade from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Stephens reissued an “equal weight” rating and set a $7.03 price objective on shares of Accolade in a research report on Wednesday, February 12th. Thirteen equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $6.51.

Accolade Stock Performance

Shares of Accolade stock opened at $7.02 on Wednesday. The company has a market capitalization of $575.59 million, a P/E ratio of -3.12 and a beta of 2.10. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.63 and a current ratio of 2.63. The company has a fifty day moving average of $7.01 and a 200 day moving average of $5.71. Accolade, Inc. has a fifty-two week low of $3.08 and a fifty-two week high of $8.05.

Accolade Company Profile

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians.